Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease.
This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical and Vaccine Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical and Vaccine Production. This report contains market size and forecasts of Biopharmaceutical and Vaccine Production in global, including the following market information:
- Global Biopharmaceutical and Vaccine Production Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Biopharmaceutical and Vaccine Production market was valued at US$ 407.72 billion in 2022 and is projected to reach US$ 651.58 billion by 2029, at a CAGR of 8.03% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biopharmaceutical Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biopharmaceutical and Vaccine Production include Novartis, Pfizer, Sanofi, Roche, Abbott, Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Johnson and Johnson and GlaxoSmithKline, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biopharmaceutical and Vaccine Production companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biopharmaceutical and Vaccine Production Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceutical and Vaccine Production Market Segment Percentages, by Type, 2022 (%)
- Biopharmaceutical
- Vaccine Production
Global Biopharmaceutical and Vaccine Production Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biopharmaceutical and Vaccine Production Market Segment Percentages, by Application, 2022 (%)
- Pharmaceutical
- Biotechnology
- Academic and Research Institutes
- Others
Global Biopharmaceutical and Vaccine Production Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biopharmaceutical and Vaccine Production Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biopharmaceutical and Vaccine Production revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Biopharmaceutical and Vaccine Production revenues share in global market, 2022 (%)
Key players include:
- Novartis
- Pfizer
- Sanofi
- Roche
- Abbott
- Regeneron Pharmaceuticals
- Alexion Pharmaceuticals
- Johnson and Johnson
- GlaxoSmithKline
- Merck
- Lonza
- FUJIFILM Diosynth Biotechnologies
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Biopharmaceutical and Vaccine Production, market overview.
- Chapter 2: Global Biopharmaceutical and Vaccine Production market size in revenue.
- Chapter 3: Detailed analysis of Biopharmaceutical and Vaccine Production company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Biopharmaceutical and Vaccine Production in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
